Clinical Trial Update: A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for the investigational drug FZ-AD005 in patients with high-grade glioma, including diffuse midline glioma and glioblast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Midline Glioma
• Glioblastoma
• High-grade Glioma

Drugs mentioned

• FZ-AD005

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: High Grade Glioma (III or IV), Diffuse Midline Glioma (DMG) | Phase 1 | Status: NOT_YET_RECRUITING